India's benchmark indexes are likely to open little changed on Tuesday, after logging their best day in more than four years ...

Indian pharma stocks fell 1.6% on Monday, bucking broader market gains, after U.S. President Trump said he would cut drug ...

Pharma stocks rise amid market drop due to limited impact from US pricing order. Discover more on what fuels this trend.

Indian pharmaceutical shares dropped up to 7% following US President Donald Trump's pledge to significantly lower US drug ...

Pharma stocks lit up Dalal Street on Tuesday as President Donald Trumps remarks on drug pricing sent mixed signals to global ...

Pharma stocks were trading higher on May 13 after better-than-feared Donald Trump’s executive order on pharma last night.

(Reuters) -Indian pharmaceutical stocks shed 1.3% on Monday, even as the broader markets rose, after U.S. President Donald ...

Indian Pharma stocks were on a strong uptrend today, with the Nifty Pharma index rising by 1.19% in intraday trade.

The Nifty Pharma Index ended 0.2% higher Monday after tumbling almost 2.4% earlier in the day in response to Trump's remarks.

US President Trump's move to cut drug prices by 30–80% may severely impact Indian pharma exports and profitability, ...

Shares of Indian pharmaceutical companies fell up to 7% after US President Donald Trump promised to sign an executive order ...